Kura Oncology (NasdaqGS:KURA) Q1 2026 Earnings call May 12, 2026 04:30 PM ET Company Participants Brian Powl - Chief Commercial Officer Greg Mann - SVP of Investor Relations and Corporate Affairs Mollie Leoni - Chief Medical Officer Tom Doyle - SVP of Finance and Accounting Troy Wilson - President and CEO Conference Call Participants Dan Bronder - Analyst Daniel Brims - Analyst David Dai - Analyst Etzer Darout - Analyst Jonathan Chang - Analyst Nabil Belhadj - Analyst Peter Green - Analyst Philip Nadeau - A ...